Modification at the 2'-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity.

MLA

Sati, Girish C., et al. “Modification at the 2’-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity.” ACS Infectious Diseases, vol. 5, no. 10, Oct. 2019, pp. 1718–30. EBSCOhost, https://doi.org/10.1021/acsinfecdis.9b00128.

APA

Sati, G. C., Sarpe, V. A., Furukawa, T., Mondal, S., Mantovani, M., Hobbie, S. N., Vasella, A., Böttger, E. C., & Crich, D. (2019). Modification at the 2’-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity. ACS Infectious Diseases, 5(10), 1718–1730. https://doi.org/10.1021/acsinfecdis.9b00128

Chicago

Sati, Girish C, Vikram A Sarpe, Takayuki Furukawa, Sujit Mondal, Matilde Mantovani, Sven N Hobbie, Andrea Vasella, Erik C Böttger, and David Crich. 2019. “Modification at the 2’-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity.” ACS Infectious Diseases 5 (10): 1718–30. doi:10.1021/acsinfecdis.9b00128.